menu
    • menu

    Company profile for Semnur Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Semnur Pharmaceuticals is focused on advancing innovative therapies for the treatment of pain. Their primary objective is to develop targeted, non-opioid pain management solutions that address significant unmet medical needs. By leveraging proprietary sustained-release technology, Semnur aims to deliver long-lasting pain relief while minimizing systemic exposure and side effects. The company's research and development efforts ...
    Semnur Pharmaceuticals is focused on advancing innovative therapies for the treatment of pain. Their primary objective is to develop targeted, non-opioid pain management solutions that address significant unmet medical needs. By leveraging proprietary sustained-release technology, Semnur aims to deliver long-lasting pain relief while minimizing systemic exposure and side effects. The company's research and development efforts are centered around providing safe and effective alternatives to opioid-based treatments, with a commitment to improving the quality of life for patients suffering from chronic pain conditions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Semnur PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    960 San Antonio Road, Palo Alto, CA, 94303
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.semnurpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scilex Closes $200M Semnur Stock-to-Bitcoin Exchange Deal
    Scilex Closes $200M Semnur Stock-to-Bitcoin Exchange Deal

    25 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/25/3156092/0/en/Scilex-Announces-Closing-of-Previously-Announced-Non-Dilutive-Value-Enhancing-Transaction-with-an-Institutional-Investor-for-the-Exchange-of-200-Million-of-Common-Stock-of-Semnur-P.html

    GLOBENEWSWIRE
    25 Sep 2025
    Share Share
    Semnur Pharma, Scilex Subsidiary, And Denali Capital Complete
    Semnur Pharma, Scilex Subsidiary, And Denali Capital Complete

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/22/3154269/0/en/Semnur-Pharmaceuticals-Inc-Semnur-a-Majority-Owned-Subsidiary-of-Scilex-Holding-Company-Nasdaq-SCLX-Scilex-and-Denali-Capital-Acquisition-Corp-Announce-the-Closing-of-Their-Previou.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share
    Semnur Pharma, Scilex Majority-Owned Subsidiary, Denali Capital
    Semnur Pharma, Scilex Majority-Owned Subsidiary, Denali Capital

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/04/3144605/0/en/Semnur-Pharmaceuticals-Inc-Semnur-a-Majority-Owned-Subsidiary-of-Scilex-Holding-Company-Nasdaq-SCLX-Scilex-and-Denali-Capital-Acquisition-Corp-Announce-Approval-from-Denali-s-Share.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share
    Semnur Pharma Secures $20M Investment for SP-102's Approval
    Semnur Pharma Secures $20M Investment for SP-102's Approval

    21 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/21/3136968/0/en/Scilex-Holding-Company-Nasdaq-SCLX-Announces-Its-Majority-Owned-Subsidiary-Semnur-Pharmaceuticals-Inc-Semnur-and-Denali-Capital-Acquisition-Corp-Have-Entered-into-a-Purchase-Agreem.html

    GLOBENEWSWIRE
    21 Aug 2025
    Share Share
    Scilex Holding Changes Record Date for Preferred Stock Dividend
    Scilex Holding Changes Record Date for Preferred Stock Dividend

    30 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/30/3002700/0/en/Scilex-Holding-Company-Announces-Change-in-Record-Date-for-its-Previously-Announced-Dividend-of-Preferred-Stock-Exchangeable-for-up-to-10-of-Scilex-s-Ownership-Interest-in-Semnur-P.html

    GLOBENEWSWIRE
    30 Dec 2024
    Share Share
    Scilex Bio Reports KDS2010 Phase 2 Alzheimer’s Trial Enrollment
    Scilex Bio Reports KDS2010 Phase 2 Alzheimer’s Trial Enrollment

    11 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/11/2995645/0/en/Scilex-Bio-a-Controlling-Interest-of-Joint-Venture-by-Scilex-Holding-Company-Reports-KDS2010-a-Novel-Oral-Tablet-Phase-2-Trial-for-Alzheimer-s-Disease-AD-Currently-Enrolling-with-U.html

    GLOBENEWSWIRE
    11 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search